skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8121

Dr Villoutreix

Editor-in-Chief:Dr Bruno Villoutreix

Dr Villoutreix is Director of Research in a French public organization dedicated to Medical & Public Health research, the Inserm Institute, at the University of Paris 5 and the University Paris Diderot-Paris 7. He has been studying and working in several cities and countries, starting with a BSc in Bordeaux (France) and a MSc in Uppsala (Sweden) in Structural Bioinformatics after spending several months in a CNRS lab in Paris (France) and at Penn State University (USA). After some training at the Central Laboratory of Biophysics in Sofia (Bulgaria) on Protein Electrostatics, he stayed several years at the Scripps Research Institute in La Jolla (USA), focusing on Protein Modeling, Structural Analysis and Protein Sequence-Structure-Function Relationships and applying computer methods to Blood Coagulation proteins, proteins from the Complement System and involved in Cancer. After his PhD in Structural Bioinformatics, he also worked in a Biotech company (VTT Biotech, Helsinki, Finland) on docking steroid hormones into antibodies. He then moved to Sweden again (Malmo University Hospital-Lund University) to analyze in silico proteins involved in cardiovascular diseases. In 2001, he was appointed Director of Research (Inserm) in Paris and was awarded an Inserm Avenir Grant to start a team in Structural Bioinformatics, Virtual Ligand Screening and Drug Design. For his 45th birthday, in 2008, Dr Villoutreix will have over 90 publications in the peer-review journals and about 20 review articles-book chapters on Protein-Structure-Functions, Structural Bioinformatics and Chemoinformatics.

His current research interests are centered on Protein Structure Analysis, Virtual Screening, in silico ADME/Tox predictions, and new computational approaches. He has many collaborations with clinicians, chemists, structural biologists, computer scientists and biologists, all working together in order to find new ways of selecting appropriate targets and to design the next generation of therapeutics.

Dr Villoutreix has served as a guest editor in several journals, as reviewer for over 20 scientific journals and is on the Editorial board of five journals in the field of bioinformatics, computer-aided drug design and protein structure-function analysis.

Apart from his scientific endeavors, he enjoys walking in the streets of big cities, oceanside running (thus once a year!), drinking coffee (not in the evening!) and reading about the different systems of Eastern and Western philosophies.



  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University